•
Shanghai Novopathway Biotechnology, a Chinese biopharmaceutical company, has entered into a strategic partnership with fellow Chinese firm PONY Biomedicine to co-develop a comprehensive one-stop service platform for small and large molecule drugs in the pre-clinical stage. This collaboration aims to offer competitive technical services and solutions to biopharmaceutical clients on…